Effect of Chronic Antidepressant Treatment on β-Receptor Coupled Signal Transduction Cascade. Which Effect Matters Most?

 

 Buy Article Permissions and Reprints

Background: ß-Receptor down-regulation has been described as a common biochemical effect of chronic treatment with many but not all antidepressant drugs. ß-Receptor activation leads to elevated intracellular levels of cAMP followed by the activation of several protein kinases which in turn activate various transcription factors. One of those, CREP has received increasing interest as an relevant component within the antidepressant drug modulated signal cascade as it represents a down-stream signal not only of the ß-receptor but also of serotonin receptor activation. Chronic treatment with many antidpressant drugs has been shown to alter CREP levels in several brain regions. While ß-receptor down-regulation by chronic antidepressant treatment has been a consistent finding, alterations of CREP levels have been observed in both direction. Similary divergent findings have been reported for BDNF a major gene targeted of CREB, where most but not all findings suggest up-regulation at least at the message level following chronic antidepressant treatment. Methods: Because of these rather divergent data, we investigated the possible effects of chronic treatment (9 or 19 days) with three different antidepressant drugs (reboxetine, citalopram, imipramine) on the individual parameters of the ß-receptor coupled signal transduction cascade. All animals were also tested for possible antidepressant effects using the forced swimming test. Results: While ß-receptor density was down-regulated by reboxetine and imipramine but not citalopram, CREB protein was only mildly elevated after 9 days, and not changed or slightly reduced after 19 days. BDNF protein levels were not or only slightly enhanced, but only for the 9 days treatment. Citalopram was most active. Under the conditions chosen, all three drugs were active in the forced swimming test. Conclusion: Taken together, the findings reported make it difficult to identify one single component of the ß-receptor coupled signal transduction cascade as common final target of chronic antidepressant treatment.

Abbreviations

CERB:cAMP response element binding protein

ECT:electronconvulsive therapy

BDNF:brain derived neurotrophic factor

FST:Forced swimming test

References

• 1 Altar C A, Whitehead R E, Chen R, Wörtwein G and Madson T. Effects of electroconvulsive seizures and antidepressant drug on brain-derived neurotrophic factor protein in rat brain.  Biol Psychiatry. 2003;  54 703-709
  CrossrefPubMedGoogle Scholar
• 2 Assie M B, Charveron M, Palmier C, Puozzo C, Moret C, Briley M. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.  Neuropharmacol. 1992;  31 149-155
  CrossrefPubMedGoogle Scholar
• 3 Basso A M, Depiante-Depaoli M, Cancela L, Molina V. Seven-day variable-stress regime alters cortical beta-adrenoceptor binding and immunologic responses: reversal by imipramine.  Pharmacol Biochem Behav. 1993;  45 665-672
  CrossrefPubMedGoogle Scholar
• 4 Bradford M M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding.  Anal Biochem. 1976;  72 248-254
  CrossrefPubMedGoogle Scholar
• 5 Butterweck V, Winterhoff H, Herkenham M. St. John’s wort, hypericin and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.  Mol Psychiatry. 2001;  6 547-564
  CrossrefPubMedGoogle Scholar
• 6 Coppell A L, Pei Q, Zetterström T SC. Bi-shasic change in BDNF gene expression following antidepressant drug treatment.  Neuropharmacol. 2003;  44 903-910
  CrossrefPubMedGoogle Scholar
• 7 D’Sa C, Duman R S. Antidepressants and neuroplasticity.  Bipolar Disord. 2002;  4 183-194
  CrossrefPubMedGoogle Scholar
• 8 Dias B G, Banerjee S, Duman R S, Vaidya V A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatment in the adult rat brain.  Neuropharmacol. 2003;  45 553-563
  CrossrefPubMedGoogle Scholar
• 9 Dostert P, Benedetti MS and Poggesi I. Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor.  Eur Neuropsychopharmacol. 1997;  7 (Suppl 1) 23-35
  CrossrefPubMedGoogle Scholar
• 10 Duman R S, Nakagawa S and Malberg J. Regulation of adult neurogenesis by antidepressant treatment.  Neuropsychopharmacol. 2001;  25 836-844
  CrossrefPubMedGoogle Scholar
• 11 Duman R S, Heninger G R, Nestler E J. A molecular and cellular theory of depression.  Arch Gen Psychiatry. 1997;  54 597-606
  CrossrefPubMedGoogle Scholar
• 12 Duncan G E, Knapp E J, Little K Y, Breese G R. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain.  J Pharmacol Exp Ther. 1994;  271 1699-1704
  PubMedGoogle Scholar
• 13 Frechilla D, Otano A, Del Rio J. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex.  Prog Neuropsychopharmacol Biol Psychiatry. 1998;  22 787-802
  CrossrefPubMedGoogle Scholar
• 14 Fredricson O K. Kinetics of citalopram in test animals; drug exposure in safety studies.  Prog Neuropsychopharmacol Biol Psychiatry. 1982;  6 297-309
  PubMedGoogle Scholar
• 15 Garcha G, Smokcum R W, Stephenson J D, Weeramanthi T B. Effects of some atypical antidepressants on beta-adrenoceptor binding and adenylate cyclase activity in the rat forebrain.  Eur J Pharmacol. 1985;  108 1-7
  CrossrefPubMedGoogle Scholar
• 16 Hosoda K and Duman R S. Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatment and norepinephrine depletion in rat frontal cortex.  J Neurochem. 1993;  60 1335-1343
  PubMedGoogle Scholar
• 17 Hyttel J, Overo KF and Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.  Psychopharmacol. 1984;  83 20-27
  PubMedGoogle Scholar
• 18 Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951: 193 265-193 275
  Google Scholar
• 19 Malberg J E, Eisch A J, Nestler EJ Duman R S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.  J Neurosci. 2000;  20 9104-9110
  PubMedGoogle Scholar
• 20 Manier D H, Shelton RC and Sulser F. Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P ?.  J Neural Transm. 2002;  109 91-99
  CrossrefPubMedGoogle Scholar
• 21 Martin J V, Edwards E, Johnson J O, Henn F A. Monoamine receptors in an animal model of affective disorder.  J Neurochem. 1990;  55 1142-1148
  PubMedGoogle Scholar
• 22 Morinobu S, Russel D S, Sugawara S, Takahashi M. Fujimaki K. Regulation of phospharylation of cyclic AMP response element-binding protein by paroxetine treatments.  Clin Neuropharmacol. 2000;  23 106-109
  PubMedGoogle Scholar
• 23 Nibuya M, Nestler E J, Dumas R S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.  J Neurosci. 1996;  16 2365-2372
  PubMedGoogle Scholar
• 24 Odagaki Y, Garcia-Sevilla J A, Huguelet P, La Harpe R, Koyama T, Guimon J. Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims.  Brain Res. 2001;  898 224-231
  CrossrefPubMedGoogle Scholar
• 25 Paul I A, Duncan G E, Kuhn C, Mueller R A, Hong J S, Breese GR  (1990). Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling , rat strain and amine uptake.  J Pharmacol Exp Ther. 1990;  252 997-1005
  PubMedGoogle Scholar
• 26 Porsolt R D, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatment.  Eur J Pharmacol. 1978;  47 379-391
  CrossrefPubMedGoogle Scholar
• 27 Porsolt R D, Bertin A, Blavet N, Deniel M, Jalfre M. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and Serotonin activity.  Eur J Pharmacol. 1979;  57 201-210
  CrossrefPubMedGoogle Scholar
• 28 Radka S F, Holst P A, Fritsche M, Altar C A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay.  Brain Res. 1996;  709 122-130
  CrossrefPubMedGoogle Scholar
• 29 Riva M A, Brunello N, Rosescalli A C, Galimberti R, Carfragna N. Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: behavioural and biochemical studies.  J Drug Dev. 1989;  1 243-253
  PubMedGoogle Scholar
• 30 Rossby S P, Sulser F. Antidepressants: events beyond the synapse. In: Skolnick P (ed) Antidepressants: new pharmacological strategies. The Humana Press Inc Totowa; 1997: pp 195-212
  Google Scholar
• 31 Rossby S P, Manier D H, Liang S, Nalepa I, Sulser F. Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptors.  Int J Neuropsychopharmacol. 1999;  2 1-8
  PubMedGoogle Scholar
• 32 Santarelli L, Saxe M, Gross C, Surget a, Battaglia F, Dulawa S, Weisstaub N, Lee J, Fuman R, Arancio O, Belzung C, Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.  Science. 2003;  301 805-809
  CrossrefPubMedGoogle Scholar
• 33 Schwaninger M, Schofl C, Blume R, Rossig L, Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription.  Mol Pharmacol. 1995;  47 1112-1118
  PubMedGoogle Scholar
• 34 Simbrey K, Winterhoff H, Butterweck V. Extracts of St. John’s wort and various constituents affect ß-adrenergic binding in rat frontal cortex.  Life Sci. 2004;  74 1027-1038
  CrossrefPubMedGoogle Scholar
• 35 Sulser F, Vetulani J and Mobley P L. Mode of action of antidepressant drugs.  Biochem Pharmacol. 1978;  27 257-261
  CrossrefPubMedGoogle Scholar
• 36 Thome J, Sakai N, Shin K, Steffen C, Zhang Y J, Impey S, Storm D, Duman R S. CAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.  J Neurosci. 2000;  20 4030-4036
  PubMedGoogle Scholar
• 37 Vaidya V A, Siuciak J A, Du F, Duman R S. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures.  Neurosci. 1999;  89 157-166
  CrossrefPubMedGoogle Scholar
• 38 Xu H, Richardson S and Li X M. Dose-related effects of chronic antidepressants on neuroprotektive protein BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus.  Neuropsychopharmacol. 2003;  28 53-62
  PubMedGoogle Scholar

Prof. Dr. Walter E. Müller

Department of Pharmacology Biocenter

University of Frankfurt

60439 Frankfurt

Germany

Email: pharmacolNat@em.uni-frankfurt.de